FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

900000000000523009: POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001150016 POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001151017 POSSIBLY EQUIVALENT TO association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


50108 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Driving instructor (& [private]) Private driving instructor
Driving instructor (& [private]) Private driving instructor
Driving licence Has driver's license (finding)
Driving licence: [refused] or [loss of] Driving license refused (finding)
Driving licence: [refused] or [loss of] Loss of driving licence
Driving licence: [refused] or [loss of] Driving license refused (finding)
Driving licence: [refused] or [loss of] Loss of driving licence
Driving license Has driver's license (finding)
Driving/traffic examiner Driving examiner
Driving/traffic examiner Traffic examiner
Dropped beat QRS complex dropped
Dropped beat Premature beats
Dropped beats - heart Premature beats
Dropped beats - heart QRS complex dropped
Drops dose form Oral solution
Droxidopa 100mg capsule Droxidopa 100 mg oral capsule
Droxidopa 200mg capsule Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug)
Droxidopa 300mg capsule Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug)
Drug &/or toxic polyneuropathy Toxic polyneuropathy
Drug AND/OR toxin-induced diarrhea Infectious diarrheal disease
Drug AND/OR toxin-induced diarrhea Diarrhea caused by drug
Drug Rx stopped - end of trial Drug treatment stopped at end of clinical trial (situation)
Drug abuse Episode of harmful substance use
Drug abuse Harmful pattern of substance use (disorder)
Drug abuse prevention Prevention of harmful pattern of substance use (procedure)
Drug abuse prevention assessment Assessment of prevention of harmful pattern of substance use (procedure)
Drug abuse prevention education Substance abuse prevention education
Drug abuse prevention management Management of prevention of harmful pattern of substance use (procedure)
Drug abuse, continuous Continuous harmful pattern of substance use
Drug addict: [notific to CMO] or [HS2A 1(Rev) to HO] Drug addiction notification
Drug addict: [notific to CMO] or [HS2A 1(Rev) to HO] Drug addiction notification
Drug addict: [renotif to CMO] or [renotif-HS2A to HO] Drug addiction notification
Drug addict: [renotif to CMO] or [renotif-HS2A to HO] Drug addiction notification
Drug addiction notification (& admin) Drug addiction notification
Drug addiction notification Drug addiction notification
Drug allergen Substance
Drug allergy Allergic reaction to drug
Drug allergy Allergy to drug
Drug and heavy metal Drug or medicament (substance)
Drug and heavy metal Heavy metal
Drug builder Drug excipient
Drug dependence: [absinthe] or [other specified] Absinthe addiction
Drug dosage medication Drug dosage education (procedure)
Drug dose form Basic dose form (basic dose form)
Drug dose form Pharmaceutical dose form (dose form)
Drug emulsion Emulsion
Drug for the treatment of gout adverse reaction Colchicum alkaloid adverse reaction
Drug for the treatment of gout adverse reaction Uricosuric agent adverse reaction
Drug for the treatment of gout adverse reaction Colchicine adverse reaction
Drug groups primarily affecting the cardiovascular system Pharmaceutical / biologic product (product)
Drug induced: [agranulocytosis] or [neutropenia] Drug-induced neutropenia
Drug lotion Lotion (basic dose form)
Drug lotion, 0,025% Lotion (basic dose form)
Drug lotion, 0,05% Lotion (basic dose form)
Drug lotion, 0,1% Lotion (basic dose form)
Drug lotion, 0,25% Lotion (basic dose form)
Drug lotion, 0,5% Lotion (basic dose form)
Drug lotion, 1% Lotion (basic dose form)
Drug lotion, 2,5% Lotion (basic dose form)
Drug measurement Measurement of substance (procedure)
Drug monitoring not required Medication monitoring not indicated
Drug not taken - pat disbelief Drugs not taken/completed
Drug or toxin Toxin
Drug or toxin Drug or medicament (substance)
Drug overdose Overdose
Drug overdose of undetermined intent Overdose
Drug paste Paste
Drug paste, 0,5% Paste
Drug photoallergic response Photosensitivity caused by drug (disorder)
Drug powder Powder (basic dose form)
Drug powder and solvent Powder (basic dose form)
Drug prescription Prescription of drug
Drug prescription Medicinal prescription record
Drug reaction - anti-inflammatory analgesic Non-steroidal anti-inflammatory drug adverse reaction (disorder)
Drug reaction - anti-inflammatory analgesic Non-steroidal anti-inflammatory drug adverse reaction (disorder)
Drug reaction - endocrine NOS Adverse reaction to hormone
Drug reaction - endocrine NOS Adverse reaction to hormone
Drug reaction - endocrine drug Adverse reaction to hormone
Drug reaction - endocrine drug Adverse reaction to hormone
Drug resistant Streptococcus pneumoniae Multiple drug-resistant Streptococcus pneumoniae (organism)
Drug resistant Streptococcus pneumoniae Penicillin resistant Streptococcus pneumoniae (organism)
Drug screen Measurement of substance (procedure)
Drug screening test Measurement of substance (procedure)
Drug screening test Measurement of substance (procedure)
Drug screening test Measurement of substance (procedure)
Drug solution Solution
Drug suspension Suspension
Drug therapy Chemotherapy
Drug therapy (& intramuscular injection) Chemotherapy
Drug therapy (& intramuscular injection) Drug therapy (procedure)
Drug therapy Drug therapy (procedure)
Drug therapy Drug therapy (procedure)
Drug therapy Chemotherapy
Drug therapy stopped (& on medical advice) Drug treatment stopped - medical advice
Drug therapy stopped (& on medical advice) Drug therapy discontinued (situation)
Drug therapy stopped (& on medical advice) Drug therapy discontinued (situation)
Drug therapy stopped (& on medical advice) Drug treatment stopped - medical advice
Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions Drug-induced tubulointerstitial nephritis (disorder)
Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions Heavy-metal-induced tubulointerstitial nephritis (disorder)
Drug-induced contact dermatitis Contact dermatitis
Drug-induced diffuse interstitial pulmonary fibrosis Interstitial pulmonary fibrosis due to inhalation of drug

Start Previous Page 164 of 502 Next End


Reference Sets

Reference set descriptor

Back to Start